๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Crohn Disease Colitis

Evaluation of the Accuracy of Immunostaining of Claudin 2 to Detect Active or Inactive Inflammation in Endoscopic Biopsies of IBD NCT07710287n/a1 site๐Ÿ“ San Donato Milanese IRCCS Policlinico S. Donato Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety NCT07216014Phase 41 site๐Ÿ“ Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University ยท Tests: Interleukin 23, Interleukin 23 Digestive Evolution of Children With Crohn's Disease or Ulcerative Colitis Whose Anti-TNFฮฑ Treatment Was Switched to Ustekinumab Due to Paradoxical Psoriasis, NCT07529236NA1 site๐Ÿ“ Nice Centre Hospitalier Universitaire de Nice ยท Tests: switch of anti TNF for ustekinumab for paradoxical psoriasis. Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease NCT06548399n/a1 site๐Ÿ“ Hamilton McMaster University Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Outcomes With Patient With Inflammatory Bowel Disease NCT07385807n/a2 sites๐Ÿ“ Vancouver๐Ÿ“ Vancouver University of British Columbia Pregnancy and Inflammatory Bowel Disease NCT07377188n/a1 site๐Ÿ“ Amiens Centre Hospitalier Universitaire, Amiens A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult NCT07632573Phase 11 site๐Ÿ“ Hangzhou Benethera (Shaoxing) Biotechnology Co., Ltd. ยท Tests: BDHK-2009 Tablets, Placebo Leucine-rich ฮฑ2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context NCT07621783n/a1 site๐Ÿ“ Bonheiden Imelda GI Clinical Research Center ยท Tests: Leucine-rich ฮฑ2-glycoprotein Impact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic Inflammatory Bowel Diseases NCT07305454n/a1 site๐Ÿ“ Toulouse University Hospital, Toulouse ยท Tests: Inflammatory Bowek Disk Questionnaires, Short-International Physical Activity Questionnaries High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy NCT04331639n/a1 site๐Ÿ“ Boston Boston Children's Hospital ยท Tests: vitamin D3 A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease NCT07483073Phase 270 sites๐Ÿ“ Scottsdale๐Ÿ“ Los Angeles๐Ÿ“ Oxnard Eli Lilly and Company ยท Tests: Mirikizumab - Intravenous (IV), Mirikizumab - Subcutaneous (SC), LY4395089 Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease NCT06780683n/a6 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou๐Ÿ“ Meizhou Xiang Gao ยท Tests: Upadacitinib TIDHI Mental Health in IBD Patients Study NCT07013578NA1 site๐Ÿ“ North York TIDHI Innovation Inc. ยท Tests: Healing Circuitsโ„ข sessions, self-directed Healing Circuitsโ„ข curriculum Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD NCT07431983n/a2 sites๐Ÿ“ Hyderabad๐Ÿ“ Hyderabad Asian Institute of Gastroenterology, India CEDUR - German IBD Registry NCT07319442n/a1 site๐Ÿ“ Hamburg ImmunoRegister gUG A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) NCT06764615Phase 216 sites๐Ÿ“ Glen Burnie๐Ÿ“ Tyler๐Ÿ“ Chongqing Takeda ยท Tests: Zasocitinib Intestinal Ultrasound Guided Management in Inflammatory Bowel Disease NCT07775352NA1 site๐Ÿ“ Bangkok Mahidol University ยท Tests: Intestinal ultrasound (IUS), Standard of care Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011) NCT06651281Phase 337 sites๐Ÿ“ Bristol๐Ÿ“ Ypsilanti๐Ÿ“ Liberty Merck Sharp & Dohme LLC ยท Tests: Tulisokibart, Placebo to tulisokibart Comparing Diagnostic Accuracy of High-end Intestinal Ultrasound Versus Mid-end Ultrasound With Tandem Ileo-colonoscopy in Inflammatory Bowel Disease : a Paired, Validating Confirmatory Study NCT06938295NA1 site๐Ÿ“ Hyderabad Asian Institute of Gastroenterology, India ยท Tests: Comparative Use of High-End and Mid-End Intestinal Ultrasound Devices for IBD Disease activity assessment Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease. NCT06298461Phase 41 site๐Ÿ“ Winnipeg University of Manitoba ยท Tests: KleanLyte, Bi-PegLyte A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-severe Inflammatory Bowel Disease NCT07758101Phase 11 site๐Ÿ“ Hangzhou Guangdong Hengrui Pharmaceutical Co., Ltd ยท Tests: SHR-7590, Placebo Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI) NCT07670975n/a1 site๐Ÿ“ Alessandria Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo diโ€ฆ ยท Tests: Indirect Calorimetry PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease NCT06758024NA1 site๐Ÿ“ Santiago Pontificia Universidad Catolica de Chile ยท Tests: Infliximab, Infliximab Molecular Inflammation Board at the Center for Personalized Medicine NCT07132333n/a1 site๐Ÿ“ Tรผbingen University Hospital Tuebingen ยท Tests: Biologic Agent A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis NCT07606339n/a1 site๐Ÿ“ Vienna Janssen-Cilag Pharma GmbH Body Composition Assessment and Monitoring in Inflammatory Bowel Disease NCT07162701n/a1 site๐Ÿ“ Barcelona Fundaciรณ Institut de Recerca de l'Hospital de la Santa Creuโ€ฆ ยท Tests: Bioimpedance analysis Long-term Treatment With Ustekinumab in Patients With Crohn's Disease and Ulcerative Colitis: a Cohort Study NCT06802887n/a1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Familial Inflammatory Bowel Disease Early Risk NCT07791862n/a1 site๐Ÿ“ Seattle Seattle Children's Hospital IBD Biomarker Discovery and Validation Platform NCT07686406n/a2 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease NCT07644117n/a1 site๐Ÿ“ Tel Aviv Shmuel Kivity, MD ยท Tests: This is an observational study with no intervention. Patients will receive anti- TNF therapy as part of their standard โ€ฆ
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy